Neimeth International Pharmaceuticals Plc (NGX: NEIMETH)

Market Cap	13.46B
Revenue (ttm)	3.79B
Net Income (ttm)	-1.98B
Shares Out	4.27B
EPS (ttm)	-0.46
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,603,739
Average Volume	2,134,760
Open	3.390
Previous Close	3.100
Day's Range	3.150 - 3.390
52-Week Range	1.510 - 3.800
Beta	0.34
RSI	56.02
Earnings Date	Jan 28, 2025

About NGX: NEIMETH

Neimeth International Pharmaceuticals Plc manufactures and markets pharmaceutical and animal health care products in Nigeria and Ghana. The company operates through two segments, Pharmaceuticals and Animal Health. It also provides health care, ethical, and veterinary related products; and poultry and a range of anthelmintic products, as well as enhancing medicaments. The company was formally known as Pfizer Inc. and changed its name to Neimeth International Pharmaceuticals Plc. In 1997. Neimeth International Pharmaceuticals Plc was incorporated...

• Industry: Pharmaceutical Preparations
• Founded: 1957
• Employees: 202
• Stock Exchange: Nigerian Stock Exchange
• Ticker Symbol: NEIMETH

Financial Performance

In 2023, NEIMETH's revenue was 2.21 billion, a decrease of -24.31% compared to the previous year's 2.92 billion. Losses were -2.87 billion, 781.5% more than in 2022.